Lynparza 100mg Tablet – Olaparib 100mg for Ovarian & Breast Cancer
Lynparza 100mg Tablet is a targeted anti-cancer prescription medicine containing Olaparib 100mg, manufactured by AstraZeneca. It is a PARP inhibitor used in the treatment of ovarian and breast cancer, blocking an enzyme that helps cancer cells repair damaged DNA so that tumour cells die off and growth slows.
Key Features
- Contains Olaparib 100mg, a targeted PARP inhibitor
- Used in the treatment of ovarian and breast cancer
- Offers a maintenance therapy option that can delay further chemotherapy
- Manufactured by AstraZeneca
- Prescription-only (Rx) oncology medicine, strip of 8 film-coated tablets
Composition
- Olaparib – 100mg
Uses & Benefits
- Treatment of ovarian cancer, including newly diagnosed and recurrent cases
- Treatment of breast cancer as part of a targeted therapy regimen
- Specifically inhibits PARP in cancer cells while sparing most healthy cells
- Can help slow disease progression and improve overall outcomes
Directions for Use
- Take strictly in the dose and duration advised by your oncologist
- Swallow the tablet whole; do not chew, crush or split it
- May be taken with or without food, at the same time each day
- Do not stop or alter the dose without consulting your doctor
Precautions
- To be sold strictly on the prescription of a Registered Medical Practitioner
- Avoid grapefruit or grapefruit juice during treatment
- Regular blood tests are needed to monitor blood cell counts and liver function
- Common side effects include nausea, vomiting, fatigue and anaemia
- Can harm an unborn baby – use effective contraception during and after treatment
- Not recommended during pregnancy or breastfeeding
- Do not start new medicines or supplements without consulting your doctor
Storage
- Store as per label directions in a cool, dry place away from direct sunlight
- Keep out of reach and sight of children
Disclaimer: This is a high-cost, prescription-only oncology medicine. The information provided is for general awareness only and does not substitute professional medical advice. Please consult a Registered Medical Practitioner/oncologist before use.
Reviews
There are no reviews yet.